Purchase Order HHSN272201100551P

<p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to IG Assets Inc. for the preparation of GenBank submission files for two eukaryotic genomes, with a ceiling value of $8,000.00 and a completion date of November 23, 2011. The contract does not have a set-aside designation.</p>

This federal contract award, HHSN272201400038P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. Department of Health and Human Services (HHS) to Igenbio Inc., a minority-owned small disadvantaged business. The $5,000.00 firm fixed-price purchase order is for other functions related to GenBank data preparation, including the addition of locus tags, upload, and GenBank submission. The contract has no set-aside designation and has a completion date of...

This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract was awarded to Igenbio Inc., a minority-owned, self-certified small disadvantaged business, for the preparation of GENBANK data with locus tags and submission of 3 Granulibacter spp. The contract has a firm fixed price of $5,999.25 and a completion date of July 18,...

This $5,000.00 Firm Fixed Price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to IG Assets Inc. The contract is for the automated annotation of the Staphylococcus genome, including uploading the annotated data to the ERGO server and preparing and submitting the data to GenBank. The contract does not have a set-aside designation and was awarded on March 29, 2011, with a completion date...

<p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to IG Assets Inc. for $6,000.00. The contract is for automated annotations and upload/GenBank submission services. The contract does not have a set-aside designation. The award date is September 10, 2012 and the ultimate completion date is September 30, 2012. IG Assets Inc. is the prime contractor performing the work.</p>

This is a definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $156,240,393.28, is for &quot;Other Function - Microbial Genome Centers&quot; and does not have a set-aside designation. The contract was awarded on September 15, 2003, with a completion date of December 31, 2009. The contract type is Cost No Fee, indicating the contractor is...

This federal contract award, valued at $102,500.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Genomatix, Inc. for the provision of a turnkey hardware and software solution for next-generation sequencing (NGS) data analysis. The award included a pre-configured 1U rack mount computer, software, on-site installation, and training. The contract was awarded on a firm-fixed price basis and was not set aside for any special designation. The award was funded...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $3,938.22 firm fixed price purchase order is for the delivery of sequencing kits, with a completion date of September 14, 2015. The contract has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...

This federal contract award for $5,845.60 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the procurement of sequencing and cluster kits, with a period of performance ending on March 25, 2015. The contract was awarded on a firm fixed-price basis with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and...

This federal contract award, valued at $20,147.78, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The award was made to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, for the procurement of Illumina sequencing reagents. The contract has a firm fixed price and does not utilize any set-aside designations. Illumina holds two notable federal...